Organic foods and dietary supplements retailer Natural Grocers has posted a solid earnings quarter as it takes a break from its prior mode of rapid growth in the number of stores.
Herbalife’s share price plunged after the company reported disappointing second quarter earnings and reduced its future outlook that foresees sales possibly falling for the full year results.
President Trump has announced new 10% tariffs on an additional $300 billion world of Chinese goods. The move unveiled yesterday means tariffs will now likely apply to most dietary supplements whose ingredients come from China, sparking questions of what...
Bod Australia has stated that the absence of a clear pathway to market for its CBD products explains why APAC is “not yet on the radar” for its recently announced distribution deal with NewH2.
When Adel Villalobos first entered the nutraceutical industry, he noticed that contract manufacturers often “held brands hostage.” He started his own contract manufacturing company with a goal of being different.
New Jersey-based ingredients specialist PLT Health Solutions launched a Certified for Sports Grade version of its branded Rhodiola rosea, called RhodioLife, to the US market.
Italy’s National Institute of Health reports a number of products currently available on the Italian market that consumers should avoid due to the detection of erectile dysfunction drugs.
Providing a set of customised nutrition solutions will be key for dietary supplement firms to staying ahead of market competition in the years to come, according to Chinese firm Seven Twenty-Four Science and Technology.
A new collagen player has entered the market with a process it says reimagines the production of this popular ingredient to arrive at a product with a cleaner sustainability story.
Europe’s cannabidiol food and supplements market was on display at a recent CBD expo in Berlin, with CBD supplement and cosmetic manufacturers reporting impressive margins in a controversial category defined by booming sales and baffling regulations.
FDA said today it will have an update on a new regulatory structure for CBD by early fall. The announcement came via a press release on another warning issued to a CBD marketer making illegal disease claims.
Comet Bio has completed round of financing with existing investors that will assure the company can meet expected demand for its arabinoxylan prebiotic ingredient and low glycemic sweeteners, both made from recycled agricultural waste.
With the increasing globalization of the supply chain, companies will have to look to their own in house capabilities to protect themselves and their consumers from contaminated products. That’s the essence of self regulation in any case.
